In-stent Restenosis after Drug-eluting Stent Implantation in Rheumatoid Arthritis: Possible Protective Effect of Methotrexate

J Rheumatol. 2018 Aug;45(9):1336-1338. doi: 10.3899/jrheum.180171. Epub 2018 Aug 1.

Authors

Oh Chan Kwon¹, Ji Seon Oh², Yong-Gil Kim³

Affiliations

¹ Division of Rheumatology, Department of Medicine.
² Clinical Research Center.
³ Division of Rheumatology, Department of Medicine, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, South Korea. [email protected].

PMID: 30068765
DOI: 10.3899/jrheum.180171

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Antirheumatic Agents / therapeutic use*
Arthritis, Rheumatoid / complications
Arthritis, Rheumatoid / drug therapy*
Cardiovascular Diseases / etiology
Cardiovascular Diseases / surgery*
Coronary Restenosis / etiology
Coronary Restenosis / prevention & control*
Drug-Eluting Stents / adverse effects*
Female
Humans
Male
Methotrexate / therapeutic use*
Middle Aged
Percutaneous Coronary Intervention*
Treatment Outcome

Substances

Antirheumatic Agents
Methotrexate